X-ray structure breakthroughs in the GPCR transmembrane region.
暂无分享,去创建一个
[1] Oliver P. Ernst,et al. Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.
[2] Frank E. Blaney,et al. 4.26 – Seven Transmembrane G Protein-Coupled Receptors: Insights for Drug Design from Structure and Modeling , 2007 .
[3] Ferran Sanz,et al. Multi‐Receptor Binding Profile of Clozapine and Olanzapine: A Structural Study Based on the New β2 Adrenergic Receptor Template , 2008, ChemMedChem.
[4] R. Vogel,et al. Conformations of the Active and Inactive States of Opsin* , 2001, The Journal of Biological Chemistry.
[5] Marta Filizola,et al. Advances in the development and application of computational methodologies for structural modeling of G-protein-coupled receptors , 2008, Expert opinion on drug discovery.
[6] T. Lamb,et al. Dark adaptation and the retinoid cycle of vision , 2004, Progress in Retinal and Eye Research.
[7] Abby L Parrill,et al. Crystal Structures of a Second G Protein‐Coupled Receptor: Triumphs and Implications , 2008, ChemMedChem.
[8] Patrick Scheerer,et al. Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.
[9] Tetsuji Okada,et al. Photoisomerization mechanism of rhodopsin and 9-cis-rhodopsin revealed by x-ray crystallography. , 2007, Biophysical journal.
[10] Didier Rognan,et al. Protein‐based virtual screening of chemical databases. II. Are homology models of g‐protein coupled receptors suitable targets? , 2002, Proteins.
[11] Peter L. Freddolino,et al. The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[12] Stefano Costanzi,et al. On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor. , 2008, Journal of medicinal chemistry.
[13] Gebhard F. X. Schertler,et al. Projection structure of rhodopsin , 1993, Nature.
[14] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[15] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[16] R. Henderson,et al. Images of purple membrane at 2.8 A resolution obtained by cryo-electron microscopy. , 1988, Journal of molecular biology.
[17] J. Ballesteros,et al. Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.
[18] F Glaser,et al. Modeling the 3D structure of GPCRs from sequence , 2001, Medicinal research reviews.
[19] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[20] Manfred Burghammer,et al. Crystal structure of a thermally stable rhodopsin mutant. , 2007, Journal of molecular biology.
[21] Yoko Shibata,et al. Conformational thermostabilization of the β1-adrenergic receptor in a detergent-resistant form , 2008, Proceedings of the National Academy of Sciences.
[22] Vadim Cherezov,et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.
[23] Marcus Elstner,et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.
[24] D. Oprian,et al. Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296. , 1992, Biochemistry.
[25] E. Pebay-Peyroula,et al. X-ray structure of bacteriorhodopsin at 2.5 angstroms from microcrystals grown in lipidic cubic phases. , 1997, Science.
[26] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[27] Xiang-Qun Xie,et al. 3D structural model of the G‐protein‐coupled cannabinoid CB2 receptor , 2003, Proteins.
[28] R. Stenkamp. Alternative models for two crystal structures of bovine rhodopsin , 2008, Acta crystallographica. Section D, Biological crystallography.
[29] Xavier Deupi,et al. Probing the β2 Adrenoceptor Binding Site with Catechol Reveals Differences in Binding and Activation by Agonists and Partial Agonists* , 2005, Journal of Biological Chemistry.
[30] Avinash Peddi,et al. Electronic Reprint Biological Crystallography a Robotic System for Crystallizing Membrane and Soluble Proteins in Lipidic Mesophases Biological Crystallography a Robotic System for Crystallizing Membrane and Soluble Proteins in Lipidic Mesophases , 2022 .
[31] R. Henderson,et al. Molecular structure determination by electron microscopy of unstained crystalline specimens. , 1975, Journal of molecular biology.
[32] Peter L. Freddolino,et al. Prediction of structure and function of G protein-coupled receptors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[33] Olga Yuzlenko,et al. Molecular modeling of A1 and A2A adenosine receptors: Comparison of rhodopsin‐ and β2‐adrenergic‐based homology models through the docking studies , 2009, J. Comput. Chem..
[34] John P. Overington,et al. How many drug targets are there? , 2006, Nature Reviews Drug Discovery.
[35] N. Aiyar,et al. G protein-coupled receptors in drug discovery. , 2003, Assay and drug development technologies.
[36] Robert P. Millar,et al. Functional Microdomains in G-protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[37] E. Jacoby,et al. Modeling of G-protein coupled receptors with bacteriorhodopsin as a template. A novel approach based on interaction energy differences. , 1994, Journal of receptor research.
[38] Gerhard Hessler,et al. Drug Design Strategies for Targeting G‐Protein‐Coupled Receptors , 2002, Chembiochem : a European journal of chemical biology.
[39] F. Guissard,et al. Biochemical Pharmacology , 1960, Nature.
[40] R. Stevens,et al. GPCR Engineering Yields High-Resolution Structural Insights into β2-Adrenergic Receptor Function , 2007, Science.
[41] S. Moro,et al. Ligand-based homology modeling as attractive tool to inspect GPCR structural plasticity. , 2006, Current pharmaceutical design.
[42] Tetsuya Hori,et al. Crystal Structure of Squid Rhodopsin with Intracellularly Extended Cytoplasmic Region , 2008, Journal of Biological Chemistry.
[43] Peter M Fischer,et al. Role of Key Transmembrane Residues in Agonist and Antagonist Actions at the Two Conformations of the Human β1-Adrenoceptor , 2008, Molecular Pharmacology.
[44] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[45] Manfred Burghammer,et al. Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.
[46] R. Osman,et al. Minireview: Insights into G protein-coupled receptor function using molecular models. , 2001, Endocrinology.
[47] Structural biology: A moving story of receptors , 2008, Nature.
[48] Michel Bouvier,et al. Insights into signaling from the beta2-adrenergic receptor structure. , 2008, Nature chemical biology.
[49] Sid Topiol,et al. Use of the X-ray structure of the Beta2-adrenergic receptor for drug discovery. , 2008, Bioorganic & medicinal chemistry letters.
[50] Prashant V Desai,et al. Homology modeling of G-protein-coupled receptors and implications in drug design. , 2006, Current medicinal chemistry.
[51] K. Palczewski,et al. Topology of Class A G Protein-Coupled Receptors: Insights Gained from Crystal Structures of Rhodopsins, Adrenergic and Adenosine Receptors , 2009, Molecular Pharmacology.
[52] D. Rognan,et al. Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor. , 2008, Journal of medicinal chemistry.
[53] Patricia H. Reggio,et al. Computational methods in drug design: Modeling G protein-coupled receptor monomers, dimers, and oligomers , 2006, The AAPS Journal.
[54] J. Bowie,et al. Crystallization of bacteriorhodopsin from bicelle formulations at room temperature , 2005, Protein science : a publication of the Protein Society.
[55] T. Kouyama,et al. Highly Selective Separation of Rhodopsin from Bovine Rod Outer Segment Membranes Using Combination of Divalent Cation and Alkyl(thio)glucoside , 1998, Photochemistry and photobiology.
[56] Yoshinori Shichida,et al. Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[57] W. Weis,et al. Structural insights into G-protein-coupled receptor activation. , 2008, Current opinion in structural biology.
[58] Xavier Deupi,et al. Conformational complexity of G-protein-coupled receptors. , 2007, Trends in pharmacological sciences.
[59] Yael Marantz,et al. Modeling the 3D structure of GPCRs: advances and application to drug discovery. , 2003, Current opinion in drug discovery & development.
[60] Yang Xiang,et al. Sequential binding of agonists to the beta2 adrenoceptor. Kinetic evidence for intermediate conformational states. , 2004, The Journal of biological chemistry.
[61] E. Landau,et al. Structural and mechanistic insight from high resolution structures of archaeal rhodopsins , 2003, FEBS letters.
[62] William J. Welsh,et al. Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors , 2007, J. Comput. Aided Mol. Des..
[63] D C Teller,et al. Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.
[64] Peter L. Freddolino,et al. Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[65] T. Okada,et al. Local peptide movement in the photoreaction intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.
[66] Xavier Deupi,et al. Coupling ligand structure to specific conformational switches in the β2-adrenoceptor , 2006, Nature chemical biology.
[67] Yang Li,et al. Identification and Functional Characterization of Allosteric Agonists for the G Protein-Coupled Receptor FFA2 , 2008, Molecular Pharmacology.
[68] Kenneth Jones,et al. Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds. , 2008, Bioorganic & medicinal chemistry letters.
[69] M. Burghammer,et al. Crystal structure of the human b 2 adrenergic G-protein-coupled receptor , 2007 .
[70] Krzysztof Palczewski,et al. Crystal structure of a photoactivated deprotonated intermediate of rhodopsin , 2006, Proceedings of the National Academy of Sciences.
[71] Tsutomu Kouyama,et al. Crystal structure of squid rhodopsin , 2008, Nature.
[72] K Prendergast,et al. Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor. , 1994, Chemistry & biology.
[73] P Ghanouni,et al. Functionally Different Agonists Induce Distinct Conformations in the G Protein Coupling Domain of the β2Adrenergic Receptor* , 2001, The Journal of Biological Chemistry.
[74] Bernard Maigret,et al. Rhodopsin crystal: new template yielding realistic models of G-protein-coupled receptors? , 2003, Trends in pharmacological sciences.
[75] M. Caron,et al. The conserved seven-transmembrane sequence NP(X)2,3Y of the G-protein-coupled receptor superfamily regulates multiple properties of the beta 2-adrenergic receptor. , 1995, Biochemistry.
[76] T. Okada,et al. Crystallographic analysis of primary visual photochemistry. , 2006, Angewandte Chemie.
[77] H Luecke,et al. Structure of bacteriorhodopsin at 1.55 A resolution. , 1999, Journal of molecular biology.
[78] G. Schertler,et al. Low resolution structure of bovine rhodopsin determined by electron cryo-microscopy. , 1995, Biophysical journal.